Associations between lifetime classic psychedelic use and cardiometabolic diseases

Here is another study showing associations between lifetime psychedelic use and improved physical health.

Obviously this kind of cross-sectional design doesn't demonstrate any causal connection, but the repeated nature of these positive reports is intriguing and worth further investigation ... and it's reassuring that these surveys don't show the opposite pattern of psychedelic use being associated with worse physical health! The authors write: "The objective of the current study was to investigate the associations between lifetime classic psychedelic use and cardiometabolic diseases. Using data from the National Survey on Drug Use and Health (2005–2014), the present study examined the associations between lifetime classic psychedelic use and two types of cardiometabolic disease: heart disease and diabetes. Respondents who reported having tried a classic psychedelic at least once in their lifetime had lower odds of heart disease in the past year (adjusted odds ratio (aOR) = 0.77 (0.65–0.92), p = .006) and lower odds of diabetes in the past year (adjusted odds ratio (aOR) = 0.88 (0.78–0.99), p = .036). Classic psychedelic use might be beneficial for cardiometabolic health, but more research is needed to investigate potential causal pathways of classic psychedelics on cardiometabolic diseases."

Follow the link above for the whole post, or for more psychedelic news and research, visit the psychedelic health professional network homepage.